Investigators conducted a retrospective review that spanned 10 years with the goals of describing the clinical ...

Get ready to laugh as we showcase the most hilarious and spot-on celebrity impersonations from Saturday Night Live! From iconic talk show hosts to Hollywood stars, these impressions have left ...

Behind any impressive achievement are often serious sacrifices. And sometimes the sacrifices need to be understood in the ...

The combination of brain radiotherapy and chemoimmunotherapy “resulted in promising intracranial and systemic anti-tumor activity, with a manageable safety profile,” researchers wrote.

After parting ways with BeiGene in 2023, Novartis effectively bowed out of the PD-1 race. | The rising class of bispecifics ...

Where Summit Therapeutics (NASDAQ: SMMT) falls on that spectrum is a big question mark right now. It has been among the ...

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

Andrew Teschendorff, Professor at the Chinese Academy of Sciences, is developing computational systems-biological tools to ...

AstraZeneca has added to its oncology pipeline by licensing a small-molecule KRAS inhibitor from Chinese biotech Usynova ... KRAS-mutated non-small cell lung cancer (NSCLC), but target KRAS ...

So far, the Thai government’s efforts to improve its air quality have failed to address the systemic causes of the problem.

Singapore’s health minister fields questions regarding whether he had betrayed his opposition-affiliated parents, his 2011 ...

We recently published a list of Kevin O’Leary’s Stock Portfolio: 15 Stock Picks for 2025. In this article, we are going to ...